To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our Clinical Trials Program.
If you’ve been diagnosed with a hematologic irregularity, it’s important to be evaluated by hematology experts before beginning treatment. We can help.
Our Hematology Multidisciplinary Team includes hematologists, medical oncologists, radiation oncologists, pathologists, cytogeneticists, pharmacists, specialized nurse practitioners, dietitians, and social workers. The team is entirely focused on treating hematologic malignancies and shares its collective expertise to create a customized treatment plan for each patient.
Each patient receives personal attention from the Hematology Multidisciplinary Team. During your initial visit at a Karmanos location, a physician will review your medical records, medical history, and review your x-rays and pathology slides. The team meets regularly to discuss patient care issues and refine individual patient treatment plans. Depending on your diagnosis, our Hematology team may discuss your case with our Bone Marrow and Stem Cell Transplant Team to ensure the proper diagnosis and treatment plan is determined.
Here’s what patients can expect from our Hematology Multidisciplinary Team:
Among American men, prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death after lung cancer. ...
The Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations across the nation, recognizes and promotes awa...
Clinical Leader Patients may not be the only ones who may be apprehensive about participating in clinical trials; some physicians may be hesitant ...